Being inventive and entrepreneurial is core to the Life Sciences sector. Biotechnology, pharma, medical technology and diagnostics companies develop drugs, therapies and equipment that improve the quality of our lives. Doing research & development and maintaining growth require substantial resources and creativity. Equity and debt solutions, buy-and-build and capital markets are crucial to the health of the Life Sciences industry.
Products & services
Being inventive and entrepreneurial also drives NIBC. We constantly seek to develop products and services that are tailored to meet our clients’ evolving needs. We have Life Sciences expertise throughout our organisation, ranging from dedicated capital market research analysts, corporate finance and equity capital market sector teams to a wide range of financial product specialists. We look forward to sharing our expertise and international network with Life Sciences corporates and investors globally.